Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 18 | 2021 | 311 | 4.700 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 102 | 1.910 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2021 | 133 | 1.530 |
Why?
|
| Lysine | 5 | 2017 | 147 | 1.510 |
Why?
|
| Nucleosomes | 6 | 2019 | 54 | 1.410 |
Why?
|
| Chromatin | 8 | 2020 | 380 | 1.410 |
Why?
|
| Protein Processing, Post-Translational | 10 | 2019 | 371 | 1.330 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 4 | 2021 | 72 | 1.030 |
Why?
|
| Antigens, Nuclear | 2 | 2017 | 25 | 1.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 456 | 0.940 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 503 | 0.820 |
Why?
|
| Antibodies | 3 | 2018 | 350 | 0.780 |
Why?
|
| Methylation | 8 | 2021 | 251 | 0.770 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2021 | 127 | 0.770 |
Why?
|
| Leukemia | 2 | 2021 | 320 | 0.760 |
Why?
|
| Gene Rearrangement | 1 | 2021 | 170 | 0.750 |
Why?
|
| Bayes Theorem | 1 | 2021 | 361 | 0.700 |
Why?
|
| Cell Nucleus | 3 | 2020 | 579 | 0.690 |
Why?
|
| Heterochromatin | 1 | 2018 | 22 | 0.670 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 1135 | 0.660 |
Why?
|
| Sequence Analysis, DNA | 2 | 2019 | 853 | 0.660 |
Why?
|
| PHD Zinc Fingers | 1 | 2017 | 1 | 0.640 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 1074 | 0.630 |
Why?
|
| Transcription Factors | 4 | 2017 | 1565 | 0.610 |
Why?
|
| Histone Code | 3 | 2018 | 19 | 0.580 |
Why?
|
| Open Reading Frames | 1 | 2015 | 117 | 0.520 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1920 | 0.430 |
Why?
|
| Calorimetry | 1 | 2012 | 15 | 0.420 |
Why?
|
| Gene Library | 2 | 2023 | 130 | 0.410 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 82 | 0.400 |
Why?
|
| Homeodomain Proteins | 4 | 2021 | 536 | 0.400 |
Why?
|
| Antibody Specificity | 3 | 2019 | 129 | 0.370 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 479 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 217 | 0.370 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 2 | 2006 | 11 | 0.360 |
Why?
|
| Peptide Fragments | 1 | 2012 | 460 | 0.360 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2705 | 0.350 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2021 | 154 | 0.340 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2062 | 0.320 |
Why?
|
| Protein Binding | 5 | 2017 | 1456 | 0.320 |
Why?
|
| Calibration | 2 | 2019 | 99 | 0.310 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 69 | 0.310 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1208 | 0.290 |
Why?
|
| DNA | 3 | 2021 | 1294 | 0.290 |
Why?
|
| Humans | 25 | 2022 | 86644 | 0.290 |
Why?
|
| DNA Gyrase | 1 | 2005 | 2 | 0.270 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 16 | 0.270 |
Why?
|
| Cell Line | 5 | 2017 | 2468 | 0.250 |
Why?
|
| Genome | 2 | 2019 | 372 | 0.250 |
Why?
|
| Thermodynamics | 2 | 2017 | 309 | 0.240 |
Why?
|
| Escherichia coli | 2 | 2013 | 597 | 0.230 |
Why?
|
| HEK293 Cells | 2 | 2015 | 615 | 0.230 |
Why?
|
| DNA, Complementary | 1 | 2023 | 393 | 0.220 |
Why?
|
| Animals | 13 | 2020 | 26582 | 0.220 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 599 | 0.220 |
Why?
|
| Protein Isoforms | 1 | 2023 | 270 | 0.220 |
Why?
|
| Models, Molecular | 6 | 2011 | 1286 | 0.210 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2021 | 20 | 0.200 |
Why?
|
| STAT5 Transcription Factor | 1 | 2021 | 42 | 0.200 |
Why?
|
| RNA Splicing | 1 | 2022 | 142 | 0.200 |
Why?
|
| Alternative Splicing | 1 | 2022 | 201 | 0.200 |
Why?
|
| Datasets as Topic | 1 | 2021 | 71 | 0.200 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2021 | 90 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 5 | 2011 | 736 | 0.190 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2021 | 135 | 0.190 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3030 | 0.190 |
Why?
|
| Sequence Alignment | 1 | 2021 | 351 | 0.190 |
Why?
|
| Crystallography, X-Ray | 5 | 2016 | 485 | 0.180 |
Why?
|
| Computational Biology | 2 | 2020 | 528 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 279 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 266 | 0.170 |
Why?
|
| Oncogenes | 1 | 2019 | 88 | 0.170 |
Why?
|
| Transcriptome | 1 | 2023 | 580 | 0.170 |
Why?
|
| Binding Sites, Antibody | 2 | 2016 | 49 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 30 | 0.160 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2018 | 30 | 0.160 |
Why?
|
| Daunorubicin | 1 | 2018 | 78 | 0.160 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2018 | 109 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 639 | 0.160 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 63 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 223 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2018 | 179 | 0.150 |
Why?
|
| Xenopus | 2 | 2020 | 125 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2020 | 1981 | 0.140 |
Why?
|
| HeLa Cells | 2 | 2015 | 498 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 118 | 0.140 |
Why?
|
| Protein Conformation | 4 | 2007 | 881 | 0.140 |
Why?
|
| Genome, Human | 1 | 2021 | 756 | 0.140 |
Why?
|
| RNA | 1 | 2020 | 560 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2020 | 628 | 0.130 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 50 | 0.130 |
Why?
|
| Peptides | 2 | 2011 | 639 | 0.130 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2016 | 81 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 296 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 937 | 0.130 |
Why?
|
| Antigens | 1 | 2016 | 228 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 592 | 0.130 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2015 | 102 | 0.130 |
Why?
|
| Reference Standards | 1 | 2015 | 159 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2015 | 260 | 0.120 |
Why?
|
| Antibody Affinity | 1 | 2013 | 38 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2018 | 379 | 0.110 |
Why?
|
| Proteins | 1 | 2018 | 777 | 0.110 |
Why?
|
| Phenyl Ethers | 1 | 2012 | 13 | 0.110 |
Why?
|
| Ketones | 1 | 2012 | 13 | 0.110 |
Why?
|
| Tosyl Compounds | 1 | 2012 | 15 | 0.110 |
Why?
|
| Titrimetry | 1 | 2012 | 15 | 0.110 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 16 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 763 | 0.110 |
Why?
|
| Immobilized Proteins | 1 | 2012 | 14 | 0.110 |
Why?
|
| Esters | 1 | 2012 | 29 | 0.100 |
Why?
|
| Mice | 5 | 2018 | 11352 | 0.100 |
Why?
|
| Sulfhydryl Compounds | 1 | 2012 | 69 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 86 | 0.100 |
Why?
|
| Acetylation | 1 | 2011 | 121 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 128 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 1376 | 0.090 |
Why?
|
| Binding Sites | 3 | 2006 | 1098 | 0.090 |
Why?
|
| Multiprotein Complexes | 2 | 2006 | 95 | 0.080 |
Why?
|
| Mutation | 1 | 2019 | 3968 | 0.080 |
Why?
|
| Genes, Developmental | 1 | 2007 | 4 | 0.080 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 2005 | 3 | 0.070 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2005 | 20 | 0.070 |
Why?
|
| Adenosine Diphosphate | 1 | 2005 | 55 | 0.070 |
Why?
|
| DNA Topoisomerase IV | 1 | 2005 | 1 | 0.070 |
Why?
|
| Geobacillus stearothermophilus | 1 | 2005 | 10 | 0.070 |
Why?
|
| Borrelia burgdorferi | 1 | 2005 | 5 | 0.070 |
Why?
|
| RNA, Bacterial | 1 | 2006 | 108 | 0.070 |
Why?
|
| Vaccinia virus | 1 | 2005 | 19 | 0.070 |
Why?
|
| Static Electricity | 1 | 2005 | 89 | 0.070 |
Why?
|
| Electrons | 1 | 2005 | 49 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 153 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 287 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 314 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 330 | 0.060 |
Why?
|
| Neoplasms | 1 | 2019 | 2898 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2426 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 263 | 0.060 |
Why?
|
| Base Sequence | 2 | 2022 | 2330 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 2 | 2016 | 99 | 0.050 |
Why?
|
| Introns | 1 | 2022 | 289 | 0.050 |
Why?
|
| Exons | 1 | 2022 | 450 | 0.050 |
Why?
|
| Spermatogenesis | 1 | 2020 | 37 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2020 | 74 | 0.040 |
Why?
|
| Yeasts | 1 | 2019 | 49 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 696 | 0.040 |
Why?
|
| Catalysis | 2 | 2012 | 203 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 173 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 187 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2018 | 252 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 114 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 276 | 0.040 |
Why?
|
| Periodicity | 1 | 2017 | 119 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 458 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 427 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1041 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 381 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1128 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1284 | 0.030 |
Why?
|
| Heart | 1 | 2017 | 539 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2013 | 17 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1384 | 0.030 |
Why?
|
| Peptide Library | 1 | 2013 | 84 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1578 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2012 | 102 | 0.030 |
Why?
|
| Protons | 1 | 2012 | 98 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2232 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2012 | 287 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 318 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 246 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 250 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 411 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1991 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2007 | 3 | 0.020 |
Why?
|
| Transcription Factor TFIID | 1 | 2007 | 3 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2007 | 18 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 38 | 0.020 |
Why?
|
| Amino Acids | 1 | 2007 | 252 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2006 | 156 | 0.020 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 20 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 302 | 0.020 |
Why?
|
| RNA Interference | 1 | 2006 | 369 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 388 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2007 | 429 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 332 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1014 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 246 | 0.010 |
Why?
|
| Male | 1 | 2020 | 40966 | 0.010 |
Why?
|